Valance Washington/LinkedIn; Taras Oleksyk/EEBG; Walter Wolfsberger/The Oakland Post
Feb 9, 2026, 14:22
Valance Washington: An Evidence-Based View on Emerging Therapies for Thrombotic Disorders
Valance Washington, Professor at Oakland University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our latest publication — a letter in the Journal of Thrombosis and Thrombolysis offering an evidence-based view on emerging therapies for thrombotic disorders.
A quick read for clinicians and researchers navigating these challenges.”
Title: Subject: letter to the editor: platelet single-cell RNA sequencing
Authors: Valance Washington, Walter Wolfsberger, Taras Oleksyk
Read the Full Article on Journal of Thrombosis and Thrombolysis
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 9, 2026, 14:19Nathan Connell: Advancing Prophylaxis for von Willebrand Disease with HMB-002
-
Feb 9, 2026, 14:11Chayanin Tangwiriyasakul: Using NeuroAI to Estimate Stroke Perfusion Deficits
-
Feb 9, 2026, 13:56Ahmed Nasreldein: Privileged to Speak on Inequities in Stroke Care in LMICs at ISC 2026
-
Feb 9, 2026, 09:01Nicolás Federico: Aldosterone Dysregulation as a Driver of Cardiorenal Disease
-
Feb 8, 2026, 16:29Neil Blumberg: Clinical Harm Associated With Infusion of ABO Incompatible Antibody and Antigen
-
Feb 8, 2026, 16:20Paul Kim: Exciting Week of Excellent Science at the 2026 GRC on Plasminogen Activation and Extracellular Proteases
-
Feb 8, 2026, 16:12Ney Carter Borges: How RSV Hospitalization is Linked to Sharp Rise in Heart Attack and Stroke Risk
-
Feb 8, 2026, 16:07New BSH–UKHCDO Guideline on Acquired Coagulation Factor Inhibitors
-
Feb 8, 2026, 16:04Mahesan Subramaniam: Pomegranate Juice and Heart Health